Symbol:
Lypd6b
Name:
Ly6/Plaur domain containing 6B
RGD ID:
1562767
Description:
Predicted to enable acetylcholine receptor regulator activity. Predicted to be located in plasma membrane and side of membrane. Orthologous to human LYPD6B (LY6/PLAUR domain containing 6B); INTERACTS WITH 2,2',4,4'-Tetrabromodiphenyl ether; 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC362133; ly6/PLAUR domain-containing protein 6B; RGD1562767; similar to RIKEN cDNA 2310010M24
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 54,608,320 - 54,769,974 (+) NCBI GRCr8 mRatBN7.2 3 34,199,101 - 34,360,770 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 34,199,599 - 34,360,770 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 37,569,714 - 37,745,286 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 46,154,432 - 46,329,986 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 43,966,693 - 44,131,818 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 35,271,785 - 35,437,296 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 35,271,786 - 35,437,296 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 40,397,603 - 40,555,551 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 30,849,359 - 30,869,056 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 3 32,384,248 - 32,545,513 (+) NCBI Celera Cytogenetic Map 3 q12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Lypd6b Rat 17beta-estradiol multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of LYPD6B mRNA CTD PMID:30165855 Lypd6b Rat 17beta-estradiol decreases expression ISO LYPD6B (Homo sapiens) 6480464 Estradiol results in decreased expression of LYPD6B mRNA CTD PMID:31614463 Lypd6b Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 Lypd6b Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Lypd6b (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LYPD6B promoter] CTD PMID:19654925 Lypd6b Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LYPD6B mRNA CTD PMID:33387578 Lypd6b Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LYPD6B mRNA CTD PMID:32109520 Lypd6b Rat 4,4'-sulfonyldiphenol increases expression ISO Lypd6b (Mus musculus) 6480464 bisphenol S results in increased expression of LYPD6B mRNA CTD PMID:30951980 Lypd6b Rat 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of LYPD6B mRNA CTD PMID:24780913 Lypd6b Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LYPD6B mRNA CTD PMID:30047161 Lypd6b Rat all-trans-retinoic acid increases expression ISO LYPD6B (Homo sapiens) 6480464 Tretinoin results in increased expression of LYPD6B mRNA CTD PMID:21934132 Lypd6b Rat all-trans-retinoic acid decreases expression ISO LYPD6B (Homo sapiens) 6480464 Tretinoin results in decreased expression of LYPD6B mRNA CTD PMID:33167477 Lypd6b Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of LYPD6B mRNA CTD PMID:35163327 Lypd6b Rat arsane multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LYPD6B mRNA more ... CTD PMID:32525701 and PMID:39836092 Lypd6b Rat arsenic atom multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LYPD6B mRNA more ... CTD PMID:32525701 and PMID:39836092 Lypd6b Rat avobenzone decreases expression ISO LYPD6B (Homo sapiens) 6480464 avobenzone results in decreased expression of LYPD6B mRNA CTD PMID:31016361 Lypd6b Rat benzo[a]pyrene increases expression ISO LYPD6B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of LYPD6B mRNA CTD PMID:22316170 Lypd6b Rat benzo[a]pyrene decreases methylation ISO LYPD6B (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of LYPD6B promoter CTD PMID:27901495 Lypd6b Rat benzo[a]pyrene increases methylation ISO LYPD6B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of LYPD6B 3' UTR CTD PMID:27901495 Lypd6b Rat benzo[a]pyrene affects methylation ISO LYPD6B (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of LYPD6B 5' UTR CTD PMID:27901495 Lypd6b Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LYPD6B mRNA CTD PMID:25181051 Lypd6b Rat bisphenol A multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LYPD6B gene CTD PMID:31601247 Lypd6b Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LYPD6B mRNA CTD PMID:30816183 and PMID:34947998 Lypd6b Rat bisphenol A increases expression ISO Lypd6b (Mus musculus) 6480464 bisphenol A results in increased expression of LYPD6B mRNA CTD PMID:30951980 and PMID:32156529 Lypd6b Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of LYPD6B gene CTD PMID:28505145 Lypd6b Rat bisphenol F increases expression ISO Lypd6b (Mus musculus) 6480464 bisphenol F results in increased expression of LYPD6B mRNA CTD PMID:30951980 Lypd6b Rat chloroprene increases expression ISO Lypd6b (Mus musculus) 6480464 Chloroprene results in increased expression of LYPD6B mRNA CTD PMID:23125180 Lypd6b Rat copper atom decreases expression ISO Lypd6b (Mus musculus) 6480464 Copper results in decreased expression of LYPD6B mRNA CTD PMID:18579281 Lypd6b Rat copper(0) decreases expression ISO Lypd6b (Mus musculus) 6480464 Copper results in decreased expression of LYPD6B mRNA CTD PMID:18579281 Lypd6b Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of LYPD6B mRNA CTD PMID:26577399 Lypd6b Rat decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of LYPD6B mRNA CTD PMID:23640034 Lypd6b Rat diallyl trisulfide decreases expression ISO LYPD6B (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of LYPD6B mRNA CTD PMID:34995734 Lypd6b Rat dorsomorphin multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Lypd6b Rat fulvestrant multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LYPD6B gene CTD PMID:31601247 Lypd6b Rat furan increases expression EXP 6480464 furan results in increased expression of LYPD6B mRNA CTD PMID:25539665 Lypd6b Rat genistein increases expression ISO Lypd6b (Mus musculus) 6480464 Genistein results in increased expression of LYPD6B mRNA CTD PMID:32186404 Lypd6b Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of LYPD6B mRNA CTD PMID:33387578 Lypd6b Rat manganese atom multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LYPD6B mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of LYPD6B mRNA CTD PMID:39836092 Lypd6b Rat manganese(0) multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LYPD6B mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of LYPD6B mRNA CTD PMID:39836092 Lypd6b Rat manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of LYPD6B mRNA CTD PMID:28801915 Lypd6b Rat manganese(II) chloride multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LYPD6B mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of LYPD6B mRNA CTD PMID:39836092 Lypd6b Rat nickel sulfate increases expression ISO LYPD6B (Homo sapiens) 6480464 nickel sulfate results in increased expression of LYPD6B mRNA CTD PMID:22714537 Lypd6b Rat ozone multiple interactions ISO Lypd6b (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LYPD6B mRNA CTD PMID:34911549 Lypd6b Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LYPD6B mRNA CTD PMID:33387578 Lypd6b Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of LYPD6B mRNA CTD PMID:35163327 Lypd6b Rat phenylmercury acetate increases expression ISO LYPD6B (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of LYPD6B mRNA CTD PMID:26272509 Lypd6b Rat phenylmercury acetate multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYPD6B mRNA CTD PMID:27188386 Lypd6b Rat potassium chromate increases expression ISO LYPD6B (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of LYPD6B mRNA CTD PMID:22714537 Lypd6b Rat SB 431542 multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Lypd6b Rat sodium arsenate multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LYPD6B mRNA CTD PMID:32525701 Lypd6b Rat sodium arsenite increases expression ISO LYPD6B (Homo sapiens) 6480464 sodium arsenite results in increased expression of LYPD6B mRNA CTD PMID:22714537 Lypd6b Rat sodium arsenite decreases expression ISO Lypd6b (Mus musculus) 6480464 sodium arsenite results in decreased expression of LYPD6B mRNA CTD PMID:37682722 Lypd6b Rat sodium arsenite multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LYPD6B mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LYPD6B mRNA CTD PMID:39836092 Lypd6b Rat titanium dioxide affects expression ISO Lypd6b (Mus musculus) 6480464 titanium dioxide affects the expression of LYPD6B mRNA CTD PMID:23557971 Lypd6b Rat titanium dioxide increases methylation ISO Lypd6b (Mus musculus) 6480464 titanium dioxide results in increased methylation of LYPD6B gene and titanium dioxide results in increased methylation of LYPD6B promoter CTD PMID:35295148 Lypd6b Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of LYPD6B mRNA CTD PMID:33387578 Lypd6b Rat trichostatin A increases expression ISO LYPD6B (Homo sapiens) 6480464 trichostatin A results in increased expression of LYPD6B mRNA CTD PMID:24935251 and PMID:26705709 Lypd6b Rat triptonide increases expression ISO Lypd6b (Mus musculus) 6480464 triptonide results in increased expression of LYPD6B mRNA CTD PMID:33045310 Lypd6b Rat valproic acid increases expression ISO LYPD6B (Homo sapiens) 6480464 Valproic Acid results in increased expression of LYPD6B mRNA CTD PMID:23179753 more ... Lypd6b Rat valproic acid multiple interactions ISO LYPD6B (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYPD6B mRNA CTD PMID:27188386 Lypd6b Rat zoledronic acid increases expression ISO LYPD6B (Homo sapiens) 6480464 zoledronic acid results in increased expression of LYPD6B mRNA CTD PMID:24714768
17beta-estradiol (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 4,4'-sulfonyldiphenol (ISO) 6-propyl-2-thiouracil (EXP) all-trans-retinoic acid (ISO) alpha-Zearalanol (EXP) arsane (ISO) arsenic atom (ISO) avobenzone (ISO) benzo[a]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) chloroprene (ISO) copper atom (ISO) copper(0) (ISO) Cuprizon (EXP) decabromodiphenyl ether (EXP) diallyl trisulfide (ISO) dorsomorphin (ISO) fulvestrant (ISO) furan (EXP) genistein (ISO) gentamycin (EXP) manganese atom (ISO) manganese(0) (ISO) manganese(II) chloride (EXP,ISO) nickel sulfate (ISO) ozone (ISO) paracetamol (EXP) perfluorooctanoic acid (EXP) phenylmercury acetate (ISO) potassium chromate (ISO) SB 431542 (ISO) sodium arsenate (ISO) sodium arsenite (ISO) titanium dioxide (ISO) trichloroethene (EXP) trichostatin A (ISO) triptonide (ISO) valproic acid (ISO) zoledronic acid (ISO)
Lypd6b Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 54,608,320 - 54,769,974 (+) NCBI GRCr8 mRatBN7.2 3 34,199,101 - 34,360,770 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 34,199,599 - 34,360,770 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 37,569,714 - 37,745,286 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 46,154,432 - 46,329,986 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 43,966,693 - 44,131,818 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 35,271,785 - 35,437,296 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 35,271,786 - 35,437,296 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 40,397,603 - 40,555,551 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 30,849,359 - 30,869,056 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 3 32,384,248 - 32,545,513 (+) NCBI Celera Cytogenetic Map 3 q12 NCBI
LYPD6B Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 2 149,038,699 - 149,215,262 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 2 149,038,107 - 149,215,262 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 2 149,895,213 - 150,071,776 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 2 149,603,227 - 149,780,018 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 2 143,508,885 - 143,685,705 (+) NCBI Celera Cytogenetic Map 2 q23.2 NCBI HuRef 2 141,793,209 - 141,970,636 (+) NCBI HuRef CHM1_1 2 149,900,822 - 150,077,602 (+) NCBI CHM1_1 T2T-CHM13v2.0 2 149,489,053 - 149,665,643 (+) NCBI T2T-CHM13v2.0
Lypd6b Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 2 49,677,380 - 49,838,861 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 2 49,677,700 - 49,838,861 (+) Ensembl GRCm39 Ensembl GRCm38 2 49,787,340 - 49,948,849 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 2 49,787,688 - 49,948,849 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 2 49,643,206 - 49,804,366 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 2 49,609,695 - 49,770,855 (+) NCBI MGSCv36 mm8 Celera 2 51,460,729 - 51,622,118 (+) NCBI Celera Cytogenetic Map 2 C1.1 NCBI cM Map 2 28.74 NCBI
Lypd6b Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955440 15,014,264 - 15,027,648 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955440 14,865,736 - 15,028,655 (+) NCBI ChiLan1.0 ChiLan1.0
LYPD6B Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 13 25,713,273 - 25,890,555 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 2B 25,728,237 - 25,905,525 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 2B 10,647,871 - 10,825,062 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 2B 153,478,374 - 153,575,462 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 2B 153,479,334 - 153,576,190 (+) Ensembl panpan1.1 panPan2
LYPD6B Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 19 50,692,220 - 50,855,061 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 19 50,813,689 - 50,978,961 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 19 52,164,791 - 52,330,414 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 19 52,246,558 - 52,329,581 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 19 50,807,650 - 50,973,190 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 19 50,942,420 - 51,108,413 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 19 52,341,463 - 52,507,252 (+) NCBI UU_Cfam_GSD_1.0
Lypd6b Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405303 113,372,508 - 113,518,367 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936469 28,100,477 - 28,119,342 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936469 28,098,841 - 28,245,200 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
LYPD6B Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 15 2,952,546 - 2,972,920 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 15 2,957,051 - 3,179,409 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 15 2,443,118 - 2,477,085 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
LYPD6B Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 10 34,511,293 - 34,644,953 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 10 34,634,763 - 34,644,939 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666040 164,885,952 - 165,010,527 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Lypd6b
.
Predicted Target Of
Count of predictions: 169 Count of miRNA genes: 121 Interacting mature miRNAs: 147 Transcripts: ENSRNOT00000065989 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1298073 Cm13 Cardiac mass QTL 13 2.5 heart mass (VT:0007028) heart wet weight (CMO:0000069) 3 25013911 38192233 Rat 10401810 Kidm53 Kidney mass QTL 53 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 8227194 47233430 Rat 2298542 Neuinf11 Neuroinflammation QTL 11 3.9 nervous system integrity trait (VT:0010566) spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126) 3 15005422 76927699 Rat 631832 Sach1 Saccharin preference QTL 1 2.7 0.02 consumption behavior trait (VT:0002069) calculated saccharin drink intake volume (CMO:0001600) 3 27494621 44188411 Rat 737818 Hcar12 Hepatocarcinoma resistance QTL 12 2.6 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 3 29463235 118376539 Rat 631568 Bp92 Blood pressure QTL 92 2.2 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 1 39874793 Rat 9590286 Uminl1 Urine mineral level QTL 1 3.5 0.001 urine mineral amount (VT:0015086) urine electrolyte level (CMO:0000593) 3 28249687 73249687 Rat 4889966 Bss95 Bone structure and strength QTL 95 4.4 tibia area (VT:1000281) tibia-fibula cross-sectional area (CMO:0001718) 3 1 36847613 Rat 2313093 Bmd77 Bone mineral density QTL 77 2.2 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 3 27494621 50302886 Rat 12879852 Cm93 Cardiac mass QTL 93 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 3 18311454 47233430 Rat 12879853 Am5 Aortic mass QTL 5 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 3 18311454 47233430 Rat 12879854 Kidm63 Kidney mass QTL 63 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 18311454 47233430 Rat 61356 Bp37 Blood pressure QTL 37 3 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 3 30684642 75684642 Rat 1358905 Hrtrt17 Heart rate QTL 17 5.9 0.000014 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 3 10861912 89878372 Rat 12879849 Bw180 Body weight QTL 180 0.037 body mass (VT:0001259) body weight (CMO:0000012) 3 18311454 47233430 Rat 70191 BpQTLcluster4 Blood pressure QTL cluster 4 3 arterial blood pressure trait (VT:2000000) absolute change in systolic blood pressure (CMO:0000607) 3 10778704 50302886 Rat 12879850 Cm91 Cardiac mass QTL 91 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 3 18311454 47233430 Rat 2313101 Bmd76 Bone mineral density QTL 76 3.6 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 3 27494621 50302886 Rat 731172 Bp151 Blood pressure QTL 151 0.04 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 18311454 47233430 Rat 12879851 Cm92 Cardiac mass QTL 92 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 18311454 47233430 Rat 8694196 Abfw2 Abdominal fat weight QTL 2 16.58 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 3 28249687 73249687 Rat 1358885 Bp251 Blood pressure QTL 251 3.8 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 2290452 Scl56 Serum cholesterol level QTL 56 2.26 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 3 1 91609953 Rat 12879868 Am6 Aortic mass QTL 6 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 3 31426403 70668733 Rat 11565451 Bw177 Body weight QTL 177 0.002 body mass (VT:0001259) body weight (CMO:0000012) 3 31426403 70668733 Rat 1358888 Bp264 Blood pressure QTL 264 4.43 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 11565452 Kidm57 Kidney mass QTL 57 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 31426403 70668733 Rat 12879866 Cm94 Cardiac mass QTL 94 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 31426403 70668733 Rat 12879867 Cm95 Cardiac mass QTL 95 0.047 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 3 31426403 70668733 Rat 2302055 Pia30 Pristane induced arthritis QTL 30 3.5 0.001 blood autoantibody amount (VT:0003725) serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) 3 27936919 72936919 Rat 70216 Cm14 Cardiac mass QTL 14 2.1 heart mass (VT:0007028) heart wet weight (CMO:0000069) 3 31172320 163586636 Rat 1354589 Bw31 Body weight QTL 31 3.3 body mass (VT:0001259) body weight (CMO:0000012) 3 33703347 78196190 Rat 2303593 Gluco46 Glucose level QTL 46 3 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 28468571 73468571 Rat 1354590 Despr11 Despair related QTL 11 0.000031 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 3 28468571 73468571 Rat 634306 Bp140 Blood pressure QTL 140 3.3 0.0013 arterial blood pressure trait (VT:2000000) body weight (CMO:0000012) 3 17374703 35528639 Rat 2313079 Bss73 Bone structure and strength QTL 73 1.5 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 3 27494621 50302886 Rat 631647 Bp122 Blood pressure QTL 122 6.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 30684642 75684642 Rat 2313076 Bss74 Bone structure and strength QTL 74 2 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 3 27494621 50302886 Rat 1300169 Bp177 Blood pressure QTL 177 2.96 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 3 33703347 61017857 Rat 9590136 Scort3 Serum corticosterone level QTL 3 23.37 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 3 28249687 73249687 Rat 10450804 Scl70 Serum cholesterol level QTL 70 4.7 0.001 blood LDL cholesterol amount (VT:0000181) blood low density lipoprotein cholesterol level (CMO:0000053) 3 20714090 65714090 Rat 61419 Cia11 Collagen induced arthritis QTL 11 5.6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 3 30356773 98535386 Rat 8552950 Pigfal12 Plasma insulin-like growth factor 1 level QTL 12 7.3 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 3 28249687 73249687 Rat 631676 Cm8 Cardiac mass QTL 8 7.03 0.0001 aorta mass (VT:0002845) aorta weight (CMO:0000076) 3 16954708 61954708 Rat 10450794 Scl69 Serum cholesterol level QTL 69 6.3 0.001 blood LDL cholesterol amount (VT:0000181) blood low density lipoprotein cholesterol level (CMO:0000053) 3 20714090 65714090 Rat 8694386 Bw159 Body weight QTL 159 4.52 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 3 28249687 73249687 Rat 1354604 Bw36 Body weight QTL 36 2.9 body mass (VT:0001259) body weight (CMO:0000012) 3 33703347 104104347 Rat 2313049 Bss72 Bone structure and strength QTL 72 2.6 0.0001 tibia area (VT:1000281) tibia midshaft cross-sectional area (CMO:0001717) 3 27494621 50302886 Rat 2312664 Scl62 Serum cholesterol level QTL 62 0.05 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 3 1 38710544 Rat 2301400 Cm68 Cardiac mass QTL 68 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 3 31426403 70668733 Rat
D3Rat47
Rat Assembly Chr Position (strand) Source JBrowse RGSC_v3.4 3 30,835,250 - 30,835,368 UniSTS RGSC3.4 RGSC_v3.4 3 30,835,249 - 30,835,368 RGD RGSC3.4 RGSC_v3.1 3 30,731,621 - 30,731,740 RGD Celera 3 32,512,845 - 32,512,963 UniSTS RH 3.4 Map 3 511.02 RGD RH 3.4 Map 3 511.02 UniSTS SHRSP x BN Map 3 16.3599 UniSTS SHRSP x BN Map 3 16.3599 RGD Cytogenetic Map 3 q12 UniSTS
D3Got206
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 34,197,864 - 34,198,024 (+) MAPPER mRatBN7.2 Rnor_6.0 3 35,270,054 - 35,270,211 NCBI Rnor6.0 Rnor_5.0 3 40,396,403 - 40,396,560 UniSTS Rnor5.0 RGSC_v3.4 3 30,771,423 - 30,771,580 UniSTS RGSC3.4 Celera 3 32,382,555 - 32,382,673 UniSTS Cytogenetic Map 3 q12 UniSTS
RH141888
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 34,307,577 - 34,307,794 (+) MAPPER mRatBN7.2 Rnor_6.0 3 35,383,246 - 35,383,462 NCBI Rnor6.0 Rnor_5.0 3 40,503,785 - 40,504,001 UniSTS Rnor5.0 Celera 3 32,491,894 - 32,492,110 UniSTS RH 3.4 Map 3 413.32 UniSTS Cytogenetic Map 3 q12 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
7
26
113
46
45
14
20
14
6
141
66
93
45
58
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000065989 ⟹ ENSRNOP00000063299
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 34,199,599 - 34,360,770 (+) Ensembl Rnor_6.0 Ensembl 3 35,271,786 - 35,437,296 (+) Ensembl
RefSeq Acc Id:
NM_001395757 ⟹ NP_001382686
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 54,608,320 - 54,769,974 (+) NCBI mRatBN7.2 3 34,199,105 - 34,360,770 (+) NCBI
RefSeq Acc Id:
XM_039105382 ⟹ XP_038961310
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 54,608,340 - 54,769,970 (+) NCBI mRatBN7.2 3 34,199,103 - 34,360,770 (+) NCBI
RefSeq Acc Id:
XM_039105384 ⟹ XP_038961312
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 54,608,343 - 54,769,970 (+) NCBI mRatBN7.2 3 34,199,105 - 34,360,770 (+) NCBI
RefSeq Acc Id:
XM_039105387 ⟹ XP_038961315
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 54,608,343 - 54,769,970 (+) NCBI mRatBN7.2 3 34,199,105 - 34,360,770 (+) NCBI
RefSeq Acc Id:
XM_039105390 ⟹ XP_038961318
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 54,608,340 - 54,769,970 (+) NCBI mRatBN7.2 3 34,199,103 - 34,360,770 (+) NCBI
RefSeq Acc Id:
XM_063284108 ⟹ XP_063140178
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 54,608,340 - 54,769,970 (+) NCBI
RefSeq Acc Id:
XM_063284109 ⟹ XP_063140179
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 54,609,071 - 54,769,970 (+) NCBI
RefSeq Acc Id:
XM_063284110 ⟹ XP_063140180
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 54,609,019 - 54,769,970 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000063299 ⟸ ENSRNOT00000065989
RefSeq Acc Id:
XP_038961310 ⟸ XM_039105382
- Peptide Label:
isoform X1
- UniProtKB:
A6JEZ8 (UniProtKB/TrEMBL), D3ZUF1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038961318 ⟸ XM_039105390
- Peptide Label:
isoform X1
- UniProtKB:
A6JEZ8 (UniProtKB/TrEMBL), D3ZUF1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038961312 ⟸ XM_039105384
- Peptide Label:
isoform X1
- UniProtKB:
A6JEZ8 (UniProtKB/TrEMBL), D3ZUF1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038961315 ⟸ XM_039105387
- Peptide Label:
isoform X1
- UniProtKB:
A6JEZ8 (UniProtKB/TrEMBL), D3ZUF1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
NP_001382686 ⟸ NM_001395757
- Peptide Label:
precursor
- UniProtKB:
A6JEZ8 (UniProtKB/TrEMBL), D3ZUF1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063140178 ⟸ XM_063284108
- Peptide Label:
isoform X1
- UniProtKB:
A6JEZ8 (UniProtKB/TrEMBL), D3ZUF1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063140180 ⟸ XM_063284110
- Peptide Label:
isoform X1
- UniProtKB:
A6JEZ8 (UniProtKB/TrEMBL), D3ZUF1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063140179 ⟸ XM_063284109
- Peptide Label:
isoform X1
- UniProtKB:
A6JEZ8 (UniProtKB/TrEMBL), D3ZUF1 (UniProtKB/TrEMBL)
RGD ID: 13692070 Promoter ID: EPDNEW_R2595 Type: single initiation site Name: Lypd6b_1 Description: LY6/PLAUR domain containing 6B SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 3 35,271,834 - 35,271,894 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2022-09-15
Lypd6b
Ly6/Plaur domain containing 6B
Lypd6b
LY6/PLAUR domain containing 6B
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2008-09-09
Lypd6b
LY6/PLAUR domain containing 6B
RGD1562767
similar to RIKEN cDNA 2310010M24
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2008-04-30
RGD1562767
similar to RIKEN cDNA 2310010M24
RGD1562767_predicted
similar to RIKEN cDNA 2310010M24 (predicted)
'predicted' is removed
2292626 APPROVED
2006-03-07
RGD1562767_predicted
similar to RIKEN cDNA 2310010M24 (predicted)
LOC362133
similar to RIKEN cDNA 2310010M24
Symbol and Name status set to approved
1299863 APPROVED
2006-02-09
LOC362133
similar to RIKEN cDNA 2310010M24
Symbol and Name status set to provisional
70820 PROVISIONAL
